Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Latov
Norman
N
D000328:Adult; D000367:Age Factors; D002648:Child; D019317:Evidence-Based Medicine / Q000592:standards; D020275:Guillain-Barre Syndrome / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007167:Immunotherapy / Q000592:standards*; D010956:Plasmapheresis; D017410:Practice Guidelines as Topic / Q000592:standards; D010818:Practice Patterns, Physicians'
D016756:Immunoglobulins, Intravenous